Recombinant multi-species GPX4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GPX4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene belongs to the glutathione peroxidase family, members of which catalyze the reduction of hydrogen peroxide, organic hydroperoxides and lipid hydroperoxides, and thereby protect cells against oxidative damage. Several isozymes of this gene family exist in vertebrates, which vary in cellular location and substrate specificity. This isozyme has a high preference for lipid hydroperoxides and protects cells against membrane lipid peroxidation and cell death. It is also required for normal sperm development; thus, it has been identified as a 'moonlighting' protein because of its ability to serve dual functions as a peroxidase, as well as a structural protein in mature spermatozoa. Mutations in this gene are associated with Sedaghatian type of spondylometaphyseal dysplasia (SMDS). This isozyme is also a selenoprotein, containing the rare amino acid selenocysteine (Sec) at its active site. Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. Transcript variants resulting from alternative splicing or use of alternate promoters have been described to encode isoforms with different subcellular localization. [provided by RefSeq, Dec 2018]
The Alternative Names of target: GPX4,GPx-4,GSHPx-4,GSHPx-4),Glutathione peroxidase 4 (GPx-4,Gpx4,Gshpx-4,MCSP,PHGPx,Phgpx,Phospholipid hydroperoxide glutathione peroxidase GPX4,SMDS,gpx-4,mtPHGPx,snGPx,snGpx,snPHGPx
Go
to GPX4 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE1581-Ag-1/ GM-Tg-hg-SE1581-Ag-2 | Human GPX4 protein | Human |
| GM-Tg-rg-SE1581-Ag-1/ GM-Tg-rg-SE1581-Ag-2 | Rat GPX4 protein | Rat |
| GM-Tg-mg-SE1581-Ag-1/ GM-Tg-mg-SE1581-Ag-2 | Mouse GPX4 protein | Mouse |
| GM-Tg-cynog-SE1581-Ag-1/ GM-Tg-cynog-SE1581-Ag-2 | Cynomolgus/Rhesus macaque GPX4 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE1581-Ag-1/ GM-Tg-felg-SE1581-Ag-2 | Feline GPX4 protein | Feline |
| GM-Tg-cang-SE1581-Ag-1/ GM-Tg-cang-SE1581-Ag-2 | Canine GPX4 protein | Canine |
| GM-Tg-bovg-SE1581-Ag-1/ GM-Tg-bovg-SE1581-Ag-2 | Bovine GPX4 protein | Bovine |
| GM-Tg-equg-SE1581-Ag-1/ GM-Tg-equg-SE1581-Ag-2 | Equine GPX4 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE1581-Ag-1/ GM-Tg-hg-SE1581-Ag-2;
GM-Tg-rg-SE1581-Ag-1/ GM-Tg-rg-SE1581-Ag-2;
GM-Tg-mg-SE1581-Ag-1/ GM-Tg-mg-SE1581-Ag-2; GM-Tg-cynog-SE1581-Ag-1/ GM-Tg-cynog-SE1581-Ag-2; GM-Tg-felg-SE1581-Ag-1/ GM-Tg-felg-SE1581-Ag-2; GM-Tg-cang-SE1581-Ag-1/ GM-Tg-cang-SE1581-Ag-2; GM-Tg-bovg-SE1581-Ag-1/ GM-Tg-bovg-SE1581-Ag-2; GM-Tg-equg-SE1581-Ag-1/ GM-Tg-equg-SE1581-Ag-2 |
| Products Name | GPX4 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | GPX4 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GPX4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.